Abstract
Risperidone has been primarily marketed for the treatment of schizophrenia. There are reports about its potential role for the treatment of affective illness. We report here another case of a patient with psychotic depression who was treated successfully with risperidone as monotherapy. This case report suggests that risperidone can be an efficient treatment mode for psychotic depression; however, it needs more data based on controlled study.
| Original language | English |
|---|---|
| Pages (from-to) | 335-337 |
| Number of pages | 3 |
| Journal | Clinical Neuropharmacology |
| Volume | 23 |
| Issue number | 6 |
| DOIs | |
| State | Published - 1 Dec 2000 |
Keywords
- 5HT receptors
- Monotherapy
- Psychotic depression
- Risperidone
- α2-adrenergic affinities
ASJC Scopus subject areas
- Pharmacology
- Clinical Neurology
- Pharmacology (medical)
Fingerprint
Dive into the research topics of 'Risperidone in the treatment of psychotic depression'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver